A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children. The new vaccine was a virus...
The Advisory Committee on Immunization Practices has updated its vaccination recommendations for immunocompetent adults aged 65 years or older to extend the interval between receipt of the Prevnar 13 and Pneumovax 23...
A new R21/Matrix-M malaria vaccine shows 75% efficacy in a Phase2b trial – a potentially game-changing result compared to the WHO-approved RTS,S/AS01 (RTS,S) vaccine. The WHO has said it will continue with the rollout...
An new study is raising concerns about the effectiveness of the monkeypox vaccine being used in the United States and other parts of the world. The work, which has not yet been peer-reviewed, found that two doses of the...
Chikungunya virus is endemic in the Indonesian archipelago, and sporadic cases are reported from various islands, including Bali. Bali is a favorite tourist destination, and visitors should be aware of the risk of...
Researchers at Karolinska Institutet have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis. The vaccine molecules comprise nano-sized membrane vesicles...
The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world’s oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic...
Brazzaville – Africa is witnessing a surge in outbreaks of vaccine-preventable diseases over the past year. Almost 17,500 cases of measles were recorded in the African region between January and March 2022, marking a...
Invasive pneumococcal disease rates have decreased substantially in children and adults since 2010, when use of 13-valent pneumococcal conjugate vaccine in children became the standard of care. Adults 65 years of age...
The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the...